Back to Journals » Clinical and Experimental Gastroenterology » Volume 11

Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin

Total article views   HTML views PDF downloads Totals
29,463 Dovepress* 26,424+ 1,326 27,750
PubMed Central* 3,039 657 3,696
Totals 29,463 1,983 31,446
*Since 24 September 2018
Total mentioned Facebook Delicious Reddit Twitter Others
18 1 0 0 6 11

View citations on PubMed Central and Google Scholar